Skip to content

AI-assisted Diagnosis of Malignant Brain Tumors

Research on AI-assisted Diagnosis of Common Malignant Brain Tumors Based on Magnetic Resonance Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07198256
Enrollment
3000
Registered
2025-09-30
Start date
2025-09-01
Completion date
2028-12-31
Last updated
2025-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Metastases, Adult, Brain Tumor Adult, Gliomas, Lymphoma

Keywords

brain tumor, glioma, brain metastases, lymphoma, magnetic resonance imaging, artificial intelligence

Brief summary

This study aims to establish a large-scale, multi-center MRI database for malignant brain tumors. It will develop an artificial intelligence system for the segmentation and classification of multiple subtypes of brain tumors (including glioma, metastatic tumor and lymphoma et al.) using deep learning technology. This will address the issues of small sample sizes and limited classification performance in existing methods, thereby improving the accuracy of non-invasive preoperative diagnosis, reducing the need for biopsies, and having significant clinical translational value.

Detailed description

This study is mainly based on two centers, the Second Affiliated Hospital of Zhejiang University School of Medicine and the Zhejiang Cancer Hospital. It retrospectively collects cases of malignant brain tumors (including gliomas, brain metastases, and brain lymphomas) that have been confirmed by histopathology and have preoperative multimodal MRI images (mainly including CE-T1WI and T2-FLAIR). It is expected to include 3,000 cases. Axial CE-T1WI and T2-FLAIR images of all patients were obtained on 3.0T or 1.5T magnetic resonance imaging systems. A large-scale, multi-center MRI image database for common malignant brain tumors (gliomas, brain metastases, and brain lymphomas) was planned to be constructed. To address the automatic segmentation of complex lesion tissues in brain tumors and the auxiliary diagnosis of common malignant brain tumors, a deep learning technical approach was adopted. A deep learning-based multi-subtype brain tumor segmentation and classification diagnostic method was proposed, aiming to build an image artificial intelligence-assisted diagnostic system for common malignant brain tumors and improve the accuracy of auxiliary diagnosis of common brain malignancies.

Interventions

None listed

Sponsors

Zhejiang Cancer Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with glioma, brain metastases, and brain lymphoma by pathology, with the patient being at least 18 years old; preoperative MRI was complete.

Exclusion criteria

* Poor image quality; history of previous brain surgery or radiotherapy; accompanied by other intracranial lesions.

Design outcomes

Primary

MeasureTime frameDescription
Construct an AI-assisted diagnostic system for multiple subtypes of brain tumors based on deep learning.30 daysConstruct an AI-assisted diagnostic system for multiple subtypes of brain tumors based on deep learning, mainly including glioma, metastatic tumor and lymphoma.

Countries

China

Contacts

Primary ContactChao Wang, MD
wangchaosmart@zju.edu.cn8613706518691

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026